|Videos|April 29, 2022

Riad Sherif, CEO of Oculis, gives a company update on clinical trials, financing and other items in the pipeline

Author(s)Kassi Filkins

Riad Sherif, MD, CEO of Oculis, gives a company update on clinical trials for products in DME, ocular surgery, and more; plus, growing products in glaucoma treatments, team and financing updates.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME